Beijing Succeeder Technology Inc. (SHA:688338)

China flag China · Delayed Price · Currency is CNY
32.85
+0.99 (3.11%)
Mar 10, 2026, 2:04 PM CST
28.32%
Market Cap 3.31B
Revenue (ttm) 263.67M
Net Income (ttm) 87.14M
Shares Out 103.97M
EPS (ttm) 0.84
PE Ratio 37.93
Forward PE n/a
Dividend 0.33 (1.02%)
Ex-Dividend Date Jun 12, 2025
Volume 2,257,216
Average Volume 3,386,809
Open 32.32
Previous Close 31.86
Day's Range 31.94 - 33.71
52-Week Range 21.28 - 36.08
Beta 0.69
RSI 51.23
Earnings Date Apr 24, 2026

About SHA:688338

Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. The company offers coagulation testers, hemorheology testers, erythrocyte sedimentation testers, platelet aggregation testers, diagnostic reagents, quality control products. Its products are used in the prevention, screening, diagnosis, and monitoring of thrombophilia, coronary heart disease, venous thromboembolism, and other thrombotic and bleeding disorders. Beijing Succeeder Technology... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2003
Employees 274
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688338
Full Company Profile

Financial Performance

In 2025, SHA:688338's revenue was 263.67 million, a decrease of -13.80% compared to the previous year's 305.87 million. Earnings were 87.14 million, a decrease of -22.88%.

Financial Statements

News

There is no news available yet.